244 related articles for article (PubMed ID: 20558255)
1. Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism.
Roghani M; Niknam A; Jalali-Nadoushan MR; Kiasalari Z; Khalili M; Baluchnejadmojarad T
Brain Res Bull; 2010 Jul; 82(5-6):279-83. PubMed ID: 20558255
[TBL] [Abstract][Full Text] [Related]
2. Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-parkinsonism.
Jalali-Nadoushan M; Roghani M
Brain Res; 2013 Apr; 1505():68-74. PubMed ID: 23415934
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress.
Baluchnejadmojarad T; Roghani M; Mafakheri M
Neurosci Lett; 2010 Aug; 480(3):206-10. PubMed ID: 20600617
[TBL] [Abstract][Full Text] [Related]
4. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of genistein in 6-hydroxydopamine hemi-parkinsonian rat model.
Baluchnejadmojarad T; Roghani M; Nadoushan MR; Bagheri M
Phytother Res; 2009 Jan; 23(1):132-5. PubMed ID: 18693302
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
[TBL] [Abstract][Full Text] [Related]
7. Differing short-term neuroprotective effects of the fibrates fenofibrate and bezafibrate in MPTP and 6-OHDA experimental models of Parkinson's disease.
Kreisler A; Duhamel A; Vanbesien-Mailliot C; Destée A; Bordet R
Behav Pharmacol; 2010 May; 21(3):194-205. PubMed ID: 20440202
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells.
Shi XR; Hong ZY; Liu HR; Zhang YC; Zhu YZ
Neurochem Int; 2011 Jul; 58(8):851-60. PubMed ID: 21093517
[TBL] [Abstract][Full Text] [Related]
10. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
[TBL] [Abstract][Full Text] [Related]
11. The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat.
Zare K; Eidi A; Roghani M; Rohani AH
Metab Brain Dis; 2015 Feb; 30(1):205-13. PubMed ID: 25123753
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of the methanolic extract of Hibiscus asper leaves in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Hritcu L; Foyet HS; Stefan M; Mihasan M; Asongalem AE; Kamtchouing P
J Ethnopharmacol; 2011 Sep; 137(1):585-91. PubMed ID: 21704692
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
[TBL] [Abstract][Full Text] [Related]
14. Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.
Kopalli SR; Noh SJ; Koppula S; Suh YH
Neurotoxicology; 2013 Jan; 34():25-32. PubMed ID: 23068419
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
Ganser C; Papazoglou A; Just L; Nikkhah G
Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism.
Lopez-Real A; Rey P; Soto-Otero R; Mendez-Alvarez E; Labandeira-Garcia JL
J Neurosci Res; 2005 Sep; 81(6):865-73. PubMed ID: 16015598
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway.
Guo S; Yan J; Yang T; Yang X; Bezard E; Zhao B
Biol Psychiatry; 2007 Dec; 62(12):1353-62. PubMed ID: 17624318
[TBL] [Abstract][Full Text] [Related]
18. Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease.
Howells FM; Russell VA; Mabandla MV; Kellaway LA
Behav Brain Res; 2005 Dec; 165(2):210-20. PubMed ID: 16159673
[TBL] [Abstract][Full Text] [Related]
19. Amburoside A, a glucoside from Amburanacearensis, protects mesencephalic cells against 6-hydroxydopamine-induced neurotoxicity.
Leal LK; Nobre Júnior HV; Cunha GM; Moraes MO; Pessoa C; Oliveira RA; Silveira ER; Canuto KM; Viana GS
Neurosci Lett; 2005 Nov; 388(2):86-90. PubMed ID: 16039060
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease.
Delattre AM; Kiss A; Szawka RE; Anselmo-Franci JA; Bagatini PB; Xavier LL; Rigon P; Achaval M; Iagher F; de David C; Marroni NA; Ferraz AC
Neurosci Res; 2010 Mar; 66(3):256-64. PubMed ID: 19941911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
